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Abstract: The nerve tissue mini-hemoglobin from Cerebratulus lacteus (CerHb) displays 
an essential globin fold hosting a protein matrix tunnel held to allow traffic of small ligands 
to and from the heme. CerHb heme pocket hosts the distal TyrB10/GlnE7 pair, normally 
linked to low rates of O2 dissociation and ultra-high O2 affinity. However, CerHb affinity 
for O2 is similar to that of mammalian myoglobins, due to a dynamic equilibrium between 
high and low affinity states driven by the ability of ThrE11 to orient the TyrB10 OH group 
relative to the heme ligand. We present here the high resolution crystal structures of CerHb 
in the unligated and carbomonoxy states. Although CO binds to the heme with an 
orientation different from the O2 ligand, the overall binding schemes for CO and O2 are 
essentially the same, both ligands being stabilized through a network of hydrogen bonds 
based on TyrB10, GlnE7, and ThrE11. No dramatic protein structural changes are needed 
to support binding of the ligands, which can freely reach the heme distal site through the 
apolar tunnel. A lack of main conformational changes between the heme-unligated and  
-ligated states grants stability to the folded mini-Hb and is a prerequisite for fast ligand 
diffusion to/from the heme. 
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1. Introduction 
The nerve haemoglobin (Hb) from the nemertean worm Cerebratulus lacteus (CerHb) is one of the 
smallest naturally occurring known globins, being composed of 109 amino acids instead of the  
~140–160 residues typical of most globins [1,2]. Its structure shows a markedly edited globin fold with 
deletion of the N-terminal A helix, extension of the GH hinge region, and a shortened C-terminal  
H helix [3]. Both sequence and structural analyses indicate that CerHb is evolutionary equally distant 
from known globins, suggesting the presence of a specific mini-Hb family within the Hb superfamily. 
The affinity of CerHb for O2 is very close to that of mammalian myoglobins (Mbs), and its function 
has held to be the storage of O2 for release around axons and brain tissue during periods of burrowing 
under anoxic conditions [2]. From structural considerations it appears remarkable how such a small 
and altered globin structure can secure heme binding and the ensuing O2 storage function.  
Despite the minimal size of the polypeptide chain, CerHb binds the heme group according to the 
stereochemical rules observed throughout the globin superfamily [3]. The heme Fe atom is regularly 
coordinated to the proximal His(93)F8 residue (amino acids have been identified with their topological 
site numbers as defined in the conventional globin fold), while on the (ligand binding) distal site O2 
stabilization is achieved through a network of hydrogen bonds based on the three key residues: 
Tyr(11)B10, Gln(44)E7, and Thr(48)E11. Tyr(11)B10 and, to a lesser extent, Gln(44)E7 are the distal 
residues directly hydrogen-bonded to the O2 molecule, stabilizing the heme-bound form. Thr(48)E11 
participates in this process by fine tuning the Tyr(11)B10 OH group orientation relative to the O2 
ligand molecule. Indeed, structural, mutagenesis, and simulation studies indicated the presence of a 
dynamic equilibrium between high and low affinity states of CerHb heme distal site, driven by the 
ability of Thr(48)E11 to orient the Tyr(11)B10 phenolic OH group relative to the ligand in such a way 
that the heme-bound O2 would be destabilized through electrostatic repulsion of the lone electron pairs 
on the Tyr(11)B10 phenolic O atom [4,5]. As a result of such novel control mechanism in Hbs, based 
on “fractional” hydrogen bonds, the affinity of CerHb for O2 is only moderate (KO2 = 1 µM−1), and the 
rate of O2 dissociation is unexpectedly high (koff = 200–600 s−1), contrary to the enhanced O2 affinity 
normally found for TyrB10-GlnE7 containing Hbs or Mbs [6]. 
A second distinct structural feature of CerHb is the presence of a long apolar tunnel that traverses 
the interior of the globin matrix from the heme pocket to the solvent, between the C-terminal ends of 
the E and H helices [3]. This tunnel allows a relatively unhindered access to the distal portion of the 
heme pocket and correlates with an unusually large association rate constant for O2 binding to CerHb 
(k’O2 = 240 µM−1·s−1), when compared with those of other invertebrate globins containing the Tyr-Gln 
active site motif (1 to 5 µM−1·s−1) [6]. Thus, loss of the A helix, which would block access to the 
channel, may have been an adaptive strategy to allow for rapid rates of O2 exchange while retaining 
the TyrB10-GlnE7 motif [3,4]. The structural and kinetic properties of the apolar tunnel have been 
extensively examined by X-ray crystallography, ligand binding kinetics, and molecular dynamics on 
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wild type CerHb and mutants at selected sites within the tunnel (Ala(55)E18 and Leu(86)G12) [7,8]. 
All such data provide unambiguous experimental proof that diatomic ligands can enter and exit CerHb 
through the protein matrix tunnel, in preference to the more direct and “classic” E7 gate, typically 
found in Mb [9]. Some degree of structural heterogeneity has been highlighted at the E7 site, where 
both the addition of Xenon to the CerHb Leu(86)G12→Ala mutant and oxidation of wild type  
CerHb heme iron cause the appearance of an out Gln(44)E7 conformer, in which the amide side  
chain points to the solvent and appears to lower the barrier for ligand escape through the E7 gate. 
However, the observed kinetics suggest little entry and escape (<25%) through the E7 pathway, 
presumably because the in conformer, displaying an “in” conformation for residue Gln(44)E7, is  
thermodynamically favoured [8]. 
In the work presented here, we used X-ray crystallography to determine the high resolution 
structures of CerHb in the (ferrous) unligated and in the CO-bound states (1.9 Å and 1.5 Å resolution, 
respectively), and compared these to the oxygenated form of the protein previously reported. We show 
that the overall protein structure in the distal site and in the apolar tunnel is unperturbed by ligand 
binding; however, the CO and O2 ligands bind the heme Fe-atom with different orientations, while 
exploiting very similar H-bonding stabilization schemes within the distal site.  
2. Results and Discussion 
2.1. Overall Structures of CerHb in the Unligated and Carbomonoxy States 
The structure of the ferrous unligated form of CerHb (unligated-CerHb) was refined to a general  
R-factor value of 18.3% (R-free 22.1%) for data in the 25.0–1.9 Å resolution range, with ideal 
stereochemical parameters (root mean square deviation, r.m.s.d.) from ideal values for bond lengths 
0.014 Å, and for bond angles 1.3°) [10]. The final model, restrained refined with isotropic B-factors, 
contains 819 protein atoms, corresponding to residues Met(0) to Leu(109)H20, one heme prostetic 
group, 115 ordered solvent atoms (nine in two alternate positions), one glycerol molecule, two sulfate 
and one acetate anions (Table 1): Asp(9)B8 side-chains has been refined in a double side-chain 
conformation. Analysis of the electron density map at the distal iron side confirmed the absence of any 
ligand bound to the heme-Fe2+ atom (Figure 1a).  
Restrained refinement of the carbomonoxy-form of CerHb (CerHb-CO) converged to a final  
R-factor value of 14.6% (R-free 17.9%) for data in the 24.7–1.5 Å resolution range, with ideal 
stereochemical parameters (r.m.s. deviation from ideal values for bond length 0.010 Å and for bond 
angles 1.3°) [10]. The final model contains 836 protein atoms, corresponding to residues Met(0) to 
Leu(109)H20, one heme prostetic group, 123 ordered solvent atoms, one glycerol molecule, two 
sulfate and one acetate anions (Table 1). Residues Met0, Asp(9)B8, Ser(76)G2, Ser(91)G17, and 
Leu(109)H20 were refined with double side-chain conformations. Additionally, four water molecules 
and one sulphate ion were modelled in two alternate positions. B-factors were refined anisotropically. 
Analysis of the electron density map at the distal iron side clearly indicates the presence of a diatomic 
ligand bound to the heme-Fe2+ atom (Figure 1b).  
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Table 1. Data collection and refinement statistics for unligated-CerHb and CerHb-CO. 
 unligated-CerHb CerHb-CO 
Data Collection Parameters: 
Space group 
 
P212121 
 
P212121 
Cell dimensions (Å) a = 42.1 
b = 44.3 
c = 62.1 
a = 42.7 
b = 43.5 
c = 60.1 
Resolution (Å) 25.4–1.9 
(2.00–1.90) 
30.5–1.5 
(1.58–1.50) 
Observations 55,282 129,825 
Unique reflections 9,482 18,465 
Completeness (%) 98.6 (100) a 99.6 (100.0) 
R-merge b (%) 20.0 (35.7) 8.2 (31.9) 
I/σ(I) 6.0 (4.2) 13.4 (5.7)  
Multiplicity 5.8 (6.4) 7.0 (7.3) 
 
Refinement:   
R-factor c/R-free (%) 18.3/22.1 14.6/17.9 
Protein atoms in the a.u. d 
Heme prostetic group 
819 
1 
836 
1 
Carbon monoxide molecule - 1 
Water molecules 115 123 
Sulfate ions 
Acetate ions 
2 
1 
2 
1 
Glycerol 1 1 
 
Model quality:   
Overall B-factor (Å2): 
Protein and heme 
Carbon monoxide molecule 
Ions and glycerol 
Water molecules 
 
13.9 
- 
37.9 
25.8 
 
13.3 
18.9 
23.8 
27.1 
Rmsd from ideal values: 
bond lengths (Å) 
bond angles (°) 
 
0.014 
1.3 
 
0.010 
1.3 
Ramachandran plot (%) e: 
most favored regions 
additional allowed regions 
 
96.8 
3.2 
 
96.8 
3.2 
a Outer shell statistics are shown within parentheses; b R-merge = ∑h∑i |Ihi − <Ih>|/∑h∑i Ihi  
c R-factor = ∑h ||Fobs| − |Fcalc||/Σh |Fobs| where Fobs and Fcalc are the observed and calculated  
structure factor amplitudes, respectively; d asymmetric unit; e data produced using the program 
PROCHECK [10].  
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Figure 1. A view of the heme cavity in (a) unligated-CerHb, and (b) CerHb-CO, including 
distal and proximal sites, and the 2Fo-Fc electron density (blue mesh, contoured at 
1σ level) calculated at the end of the refinement process. Residues lining the heme pocket 
are shown in ball-and-stick representation (unligated-CerHb in green and CerHb-CO in 
yellow, respectively). The heme is seen edge on; the distal cavity is on the right of the heme. 
 
When compared to each other, the unligated-CerHb and CerHb-CO tertiary structures are very 
similar in their backbone, displaying a r.m.s deviation value of 0.29 Å, calculated over 109 Cα atom 
pairs (Figure 2). Furthermore, both structures conform well to those previously reported in the 
literature [3,8] (see below). In particular, the CerHb-CO backbone is nearly identical to those of other 
ligated CerHb structures, such as oxygenated CerHb (CerHb-O2), and aquo-met CerHb (CerHb-H2O), 
with r.m.s deviation values over 109 Cα atom pairs of only 0.10 Å and 0.16 Å, respectively. On the 
contrary, the unligated-CerHb structure superimposed onto CerHb-O2 and CerHb-H2O yielded r.m.s 
deviation values (over 109 Cα atom pairs) of 0.30 Å and 0.31 Å, respectively. Thus, despite a very 
good overall structural conservation, the 3D structures of CerHb in its bound states appear to cluster 
together based on the r.m.s.d. values. 
In general, the structural deviations between CerHb unligated and ligated state structures can be 
ascribed to a contained breathing mode of the protein, whose tertiary structure shrinks slightly upon 
ligand binding. Indeed, if the solvent-excluded volume (i.e. the volume inside the excluded protein 
surface, determined using a spherical probe of 1.4 Å for a water molecule) is calculated for each of the 
CerHb structures, the unligated-CerHb molecule displays a 1.5%–3% larger volume than CerHb in the 
ligated states. At the level of secondary structure, the only significant differences are localized at the 
C-terminus of the F helix and of the FG-hinge (residues 69–73), where the coordinate displacement of 
the unligated-CerHb Cα backbone relative to CerHb-CO is 0.45 Å, and at the GH-hinge (residues  
90–97), with a coordinate displacement of 0.47 Å. The net result is a small shift of the F helix away 
from the heme in the unligated structure, with the length of the Fe–His(69)F8 NE2 bond increasing 
from 2.06 Å in CerHb-CO to 2.21 Å in unligated-CerHb, while maintaining the proximal His 
azimuthal angle essentially unperturbed. For reference, in the CerHb-O2 and CerHb-H2O structures the 
Fe–His(69)F8 NE2 bond length is 2.06 Å and 2.05 Å, respectively. In the CerHb-O2 structure the heme 
group shifts slightly toward the outer rim of the globin pocket (0.29 Å) relative to its position  
Thr(48)E11 
His(69)F8 
Tyr(11)B10 
Gln(44)E7 
Phe(25)CD1 
Thr(48)E11 
His(69)F8 
Tyr(11)B10 
Gln(44)E7 
Phe(25)CD1 
CO 
a       b 
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in unligated-CerHb, and in CerHb-O2 or CerHb-H2O, however no significant differences are present 
for the iron position in the heme plane, with the iron atom only 0.08 Å out-of-plane at the proximal 
side in the unligated-CerHb.  
Figure 2. (a) Superimposition of unligated-CerHb (green) on CerHb-CO (yellow). All helical 
regions are labeled according to the globin fold topology, (b) Superimposition of CerHb-O2 
(cyan) on CerHb-CO (yellow), and (c) CerHb-H2O (magenta) on CerHb-CO (yellow). 
a     b     c 
 
2.2. CO Binding at the CerHb Distal Site 
The electron density clearly shows a diatomic ligand coordinated to the sixth coordination site of 
the heme Fe-atom in CerHb-CO (Figure 1b). On the basis of the shape of the electron density, and in 
view of the way crystals were prepared (see below), we identified and refined it as the exogenous CO 
molecule. The final refined model indicates an Fe–CO distance of 2.09 Å and an Fe–C–O angle of 
172° for CerHb-CO (Table 2 and Figure 3a), comparable to that reported for Mb-CO [11,12]. Two 
main hydrogen bonds stabilize the heme Fe2+-bound carbon monoxide molecule. On the one hand, the 
carbon monoxide O atom is linked to the Tyr(11)B10 OH group (2.64 Å), on the other, it is hydrogen 
bonded to the Gln(44)E7 NE2 atom (3.10 Å). Additional polar interactions contribute to the overall 
structural organization of the heme distal site. Specifically, the Tyr(11)B10 OH group is connected to 
the Thr(48)E11 OG1 atom by a strong hydrogen bond (2.60 Å), while weaker interactions connect the 
Tyr(11)B10 OH group to the Gln(44)E7 NE2 atom (3.06 Å), and the Gln(44)E7 NE2 atom to the 
Thr(48)E11 OG1 atom (3.56 Å). Moreover, the close contact (3.43 Å) occurring between the heme  
Fe-bound CO molecule (through its O atom) and the rim of Phe(25)CD1 should be noted, indicative of 
an aromatic-electrostatic contact, which further contributes to stabilization of the ligand (Figure 3a). 
As a result of the interlacing of side chains and hydrogen bonds, the heme Fe-bound carbon monoxide 
molecule is fully buried in the distal site, being totally inaccessible to solvent. If we compare the 
binding mode of the diatomic ligands in CerHb-CO and CerHb-O2 we notice that, despite the different 
binding geometry of the dioxygen molecule, the H-bonding network stabilizing the ligand is 
essentially the same in CerHb-CO and CerHb-O2 (Table 2 and Figure 3b). 
C  
N-term 
C-term 
F  
GH hinge 
CE hinge 
N-term 
C-term 
N-term 
C-term 
B  E  
G  
H  
FG hinge 
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Table 2. Distances between polar atoms in the distal pockets of unligated-CerHb,  
CerHb-CO, and CerHb-O2 (covalent and hydrogen bonds are indicated as solid and dashed 
lines, respectively). 
 unligated-CerHb CerHb-CO CerHb-O2 
Fe−CO (Å)  2.09  
Fe−O2 (Å)   1.94 
Fe−C−O angle (°)  172  
Fe−O1−O2 angle (°)   103 
Tyr(11)B10 OH---O (Å)  2.64  
Tyr(11)B10 OH---O2 (Å)   2.57 
Gln(44)E7 NE2---O (Å)  3.10  
Gln(44)E7 NE2---O1 (Å)   2.60 
Gln(44)E7 NE2---O2 (Å)   3.34 
Tyr(11)B10 OH---Thr(48)E11 OG1 (Å) 2.76 2.60 2.59 
Tyr(11)B10 OH---Gln(44)E7 NE2 (Å) 3.13 3.06 3.24 
Gln(44)E7 NE2---Thr(48)E11 OG1 (Å) 3.70 3.56 3.53 
Figure 3. Ligand stabilization at the heme distal site of CerHb. Stereo view of the distal 
site region in (a) CerHb-CO (yellow) and (b) CerHb-O2 (cyan). The heme iron atom is 
shown in orange. Hydrogen bonds are drawn as dashed lines. 
a 
          
His(69)F8 
Tyr(11)B10 
Thr(48)E11 
Gln(44)E7 
Phe(25)CD1 
CO 
2.64 Å 
3.10 Å 
2.60 Å 
His(69)F8 
Tyr(11)B10 
Thr(48)E11 
Gln(44)E7 
Phe(25)CD1 
CO 
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3.10 Å 
2.60 Å 
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Figure 3. Cont. 
b 
          
The distal site residues in the CerHb-CO and unligated-CerHb structures superimpose almost 
perfectly, not only in their Cα positions but also in their side-chains, with only few exceptions: in the 
presence of the ligand the Tyr(11)B10 side chain rotates about 4° away from the centre of the distal 
site, while Phe(10)B9 move slightly in by a rotation of about 9° around the Cα–Cβ bond. At the same 
time the heme plane rotates about 4° around the CHB-CHD axis, with an inwards shift of about 0.3 Å 
(Figure 4a). Thus, we can conclude that ligand binding alters very marginally the structure of the distal 
site relative to the unbound state, and that the H-bonding network responsible for the stabilization  
of the bound ligand is substantially conserved independently of the nature of the diatomic  
ligand (either CO or O2). 
2.3. Ligand Diffusion Pathway through the CerHb Apolar Tunnel 
Ligand access to the heme takes place in CerHb through a wide hour-glass-shaped protein matrix 
tunnel connecting the distal site to a surface cleft located between the E and H helices [3,7,8]. The 
tunnel is lined with small hydrophobic residues, such as Tyr(51)E14, Ile(52)E15, Ala(55)E18, 
Leu(86)G12, Leu(98), Ala(101)H12, Ile(102)H13, and Ile(105)H16, and has a diameter that varies 
between 6.9 and 5.5 Å in the narrowest part, which is close to residue Leu(86)G12. The tunnel end at 
the heme distal site is surrounded by the side chains of Val(7)B6, Phe(10)B9, and Thr(48)E11.  
His(69)F8 
Tyr(11)B10 
Thr(48)E11 
Gln(44)E7 
Phe(25)CD1 
O2 
2.60 Å 
3.34 Å 
2.57 Å 
2.59 Å 
His(69)F8 
Tyr(11)B10 
Thr(48)E11 
Gln(44)E7 
Phe(25)CD1 
O2 
2.60 Å 
3.34 Å 
2.57 Å 
2.59 Å 
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Figure 4. Stereo view of the structural superimposition of CerHb-CO (yellow) and 
unligated-CerHb (green) (a) at the distal site, and (b) at the apolar tunnel region. Relevant 
residues have been shown in stick representation. 
a 
 
b 
 
The structural comparison of unligated-CerHb and CerHb-CO 3D structures indicates that ligand 
binding does not induce any relevant conformational change in the tunnel, whose lining residues match 
almost perfectly (Figure 4b). Comparable results, relative to the tunnel residues, are found when 
unligated-CerHb and CerHb-O2 3D structures are overlayed. Such findings are particularly relevant 
since the tunnel lining residues are all involved in determining the free energy profile for ligand entry, 
as calculated using dioxygen as a probe: (i) free energy barrier of ~5.5 kcal/mol due to steric 
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Int. J. Mol. Sci. 2012, 13 8034 
 
 
restrictions posed by Val(7)B6, Phe(10)B9, Tyr(11)B10, and Thr(48)E11; (ii) small (≤1 kcal/mol) 
steric barrier near Leu(86)G12; and, (iii) a barrier of ~2 kcal/mol near Ala(55)E18 at the tunnel exit to 
solvent. Furthermore, mutational studies showed that increasing the side chain size at Leu(86)G12 and 
Ala(55)E18 increases the extent of CO geminate recombination (to ~50%), and decreases both the 
association rate k’O2 and dissociation rate kO2 with little change in affinity [7,8]. Based on our data we 
can conclude that no perturbation of the apolar tunnel occurs as a result of exogenous ligand binding 
(CO or O2); the tunnel therefore maintains identical structure and, likely, dynamic properties, 
independently of the ligation state of the protein. 
3. Experimental Section  
3.1. Crystallization of CerHb and Derivative Preparation 
CerHb was expressed and purified as described previously using a synthetic gene with codon usage 
optimized for expression in Escherichia coli [3,13]. The oxygenated derivative of CerHb (CerHb-O2) 
was crystallized by vapor diffusion techniques (protein concentration 27 mg/mL) under conditions 
matching those reported in the literature [3,13]. Elongated prismatic crystals (about 0.05 × 0.05 × 0.3 mm3) 
grew within 1 week. The unbound form of CerHb (unligated-CerHb) was prepared by soaking the 
CerHb-O2 crystals in a stabilizing-cryo solution containing 2.8 M ammonium sulfate, 50 mM sodium 
acetate, pH 5.5, 15% glycerol and 50 mM dithionite, for 30 min in a sealed well. Unligated-CerHb 
crystals were then quickly frozen in liquid nitrogen for data collection, or transferred in a sealed  
well containing the same stabilizing-cryo solution but saturated with CO for preparation of the  
CO-bound derivative (CerHb-CO). After 30 min, the CerHb-CO crystals were quickly frozen in liquid 
nitrogen for data collection. 
3.2. Data Collection, Phasing and Refinement 
High resolution data (1.9 Å for unligated-CerHb, and 1.5 Å for CerHb-CO) were collected at 100 K 
at the European Synchrotron Radiation Facility, Grenoble, France (beam line ID23-1). These crystals 
belong to the orthorombic space group P212121 (Table 1). All collected data were reduced and scaled 
using MOSFLM and SCALA [14,15], and phased by molecular replacement methods with the 
program MOLREP [16] by using the CerHb-O2 structure as the starting model (PDB accession code 
1KR7) [3]. The crystallographic refinement was performed using the program REFMAC [17], and the 
program COOT [18] was used for model building/inspection. The relevant data collection and 
refinement statistics are reported in Table 1. The program Procheck [10] was used to assess the 
stereochemical quality of the protein structures and the program 3V to calculate the solvent-excluded 
volume of the protein structures [19]. Atomic coordinates and structure factors of unligated-CerHb and 
CerHb-CO have been deposited with PDB accession codes 4AVE, and 4AVD, respectively. 
4. Conclusions  
The present study investigated the structural changes that occur in CerHb upon exogenous ligand 
binding. The crystal structure of CerHb-CO revealed that the diatomic ligand binds to the heme Fe2+ 
atom with a coordination bond length of 2.09 Å in a linear orientation (Fe–C–O angle of 172°), 
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markedly different if compared to the CerHb-O2 complex, where the diatomic ligand is coordinated to 
the heme Fe2+ atom at 1.94 Å and adopts a bent orientation, forming a 103° Fe–O1–O2 angle in the 
direction of the methinic CHD atom, thus pointing to the rear end of the heme [3]. Despite the different 
orientations, the overall binding scheme of the bound ligands is essentially the same, and stabilized 
through a network of hydrogen bonds based on Tyr(11)B10, Gln(44)E7, and Thr(48)E11. Tyr(11)B10 
and, to a lesser extent, Gln(44)E7 are the distal residues directly hydrogen-bonded to the ligand, 
stabilizing the heme-bound form. Thr(48)E11 participates in this process by fine tuning the 
Tyr(11)B10 OH group orientation relative to the ligand molecule. Interestingly, comparison of the 
CerHb unligated species with CerHb-CO and CerHb-O2 reveals that binding of a ligand to the protein 
does not induce any dramatic conformational changes in the tertiary or in the secondary structures. As 
a result, both the distal site and the apolar tunnel, which provides access to the distal site from the 
solvent, are almost identical in structure in unligated-CerHb and in CerHb-CO/O2. Thus, CerHb 
represents an example of structural divergence within the globin superfamily where a minimal fold is 
able to bind stably the heme group and to take up and store O2 when the worm is in seawater, and then 
release it to nerve tissue when the organism burrows into mud flats and becomes anoxic [2]. To do so 
CerHb adapted its tertiary structure and heme distal site to achieve a Mb-like O2 affinity  
(k’O2 = 17 µM−1·s−1, kO2 = 15 s−1, KO2 = 1.1 µM−1 for Mb), but larger rates for O2 uptake and release 
(k’O2 = 240 µM−1·s−1, kO2 = 180 s−1, KO2 = 1.3 µM−1 for CerHb) [4]. Moderate O2 affinity stems from 
the presence of a Thr residue at the E11 position (E11 is an apolar amino acid in most other animal 
globins) that tunes the equilibrium between high and low affinity states of CerHb heme distal site by 
orienting the Tyr(11)B10 phenolic OH group away from the ligand [4,5]. Conversely, the need for 
rapid rates of O2 exchange during transient periods of hypoxia appears to have led to the creation of a 
large apolar tunnel between the E and H helices coupled with the concomitant loss of the A helix [7,8]. 
Thus, the Mb-like O2 affinity of CerHb is not merely due to a similar O2 binding mode, but to a more 
complex structural adaptation. In the case of CO binding, available data show that the main difference 
in the binding process can be ascribed to CO association to the heme, which is about 50-fold faster in 
CerHb [4]. Such a property may be related to the different ligand access paths identified in the two globins 
(CerHb tunnel vs. Mb E7-gate). As a result, also the M ratio between the affinity constants for CO vs.  
O2 is about 20-fold higher in CerHb. 
Our data show that no additional structural changes are needed to promote ligand binding, which 
can freely reach, through the tunnel, the distal site; here, the Tyr(11)B10, Gln(44)E7, and Thr(48)E11 
residues provide the H-bonding network needed for ligand stabilization. 
The essentially unperturbed structure of CerHb in its different ligation states (but also in the 
absence of ligands) lends itself to few conclusive considerations. On one hand, such structural 
conservation may be expected for such a small protein, since conformational changes induced by 
ligand binding may turn into lower stability of the folded protein, or loss of heme affinity. On the other 
hand, a constant structure for the protein matrix tunnel is a prerequisite for efficient (fast) ligand 
diffusion to the heme, but also for its release. Both processes would become definitely slower if gated by 
conformational changes of residues limiting tunnel access/transit. Finally, and in consideration of the 
relatively simple architecture of CerHb, which under any aspect is an oxygen-binding globin, a molecular 
tunnel devoid of functional conformational transitions can be much more easily coded during evolution. 
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